InvestorPlace - Stock Market News, Stock Advice & Trading Tips. To assist with the company’s uplisting strategy, MindMed has retained Canaccord Genuity as its financial advisor. View Comments. The company’s announcement that it will be hitting the exchange came Friday morning, and drove the stock up over 65% in the last trading session of the week. best . #5 - MindMed cannot be uplisted because they do not meet the required Share Price. JR Rahn is the cofounder and co-CEO of MindMed, a[-]psychedelic drug development company based in New York. report. save. As part of the company’s plan to expand its American shareholder base, MindMed announced on Monday that it applied with the NASDAQ to list its shares to the national U.S. exchange. By … There can be no assurance that NASDAQ acceptance will be granted. It's friday. Why a MindMed uplisting on the NASDAQ will be a pivotal event There are also three reasons to expect a MindMed uplisting to be an important sector driver, and again two of these reasons are closely related. NASDAQ UPLISTING IS FINALLY HERE! 11. As such, the stock is already up around 47%. 10. youtu.be/wEdS6Z... 0 comments. NEW YORK, Sept. 21, 2020 /CNW/ — Mind Medicine (MindMed) Inc. (NEO: MMED)(OTCQB: MMEDF)(DE: MMQ), the leading drug development company for psychedelic inspired medicines, is evaluating an expanded United States investor base through an up-listing on the NASDAQ Capital Market (“NASDAQ”). Note: uplisting announced April 23rd In September 2020, MindMed announced their application to list on the Nasdaq. No further information on the Nasdaq application was provided by the company, aside from the statement that no assurances can provided that the Nasdaq will approve of the application. Why a MindMed uplisting on the NASDAQ will be a pivotal event There are also three reasons to expect a MindMed uplisting to be an important sector driver, and again two of these reasons are closely related. As part of this up-listing strategy in the United States, MindMed has submitted an … In other words, uplisting to the Nasdaq could be any day now, or not until after March 3rd. The listing of MindMed's shares on NASDAQ will be subject to a number of regulatory requirements, including review of the company and acceptance for listing by NASDAQ. 536. MindMed Announces Filing of Preliminary Base Shelf Prospectus and F-10 with the SEC under MJDS. Mind Medicine (MindMed) Inc. (NEO: MMED)(OTCQB: MMEDF)(DE: MMQ), the leading drug development company for psychedelic inspired medicines, is evaluating an expanded United States investor base through an up-listing on the NASDAQ Capital Market (“NASDAQ”). This is in contrast to its market open on the 23rd April, prior to the uplisting announcement, when MMEDF traded at $2.895. MMEDF. American investors without access to the NEO exchange are left with only one option – the OTC. The listing of MindMed's shares on NASDAQ will be subject to a number of regulatory requirements, including review of the company and acceptance for listing by NASDAQ. Today, the company announced the success of its application. Be the first to share what you think! Well capitalized for psychedelic drug success Since that time, MindMed has closed on an upsized CAD$28.75 million financing. However, some of the more obscure listing requirements, specifically the Nasdaq’s “seasoning rules”, block MindMed from uplisting until May of this year. There can be no assurance that NASDAQ acceptance will be granted. no comments yet. What that means for investors in psychedelic stocks without access to the Nasdaq can be assurance... On Nasdaq Following Compass Pathways IPO and sector enthusiasts aren ’ t usually deterred by this, they understand end... Retained Canaccord Genuity as its financial advisor has six medications and treatment protocols currently clinical... Mindmed Inc ( MMEDF ) of mindmed, a [ - ] psychedelic drug company! Nasdaq acceptance will be granted Stock price reacted strongly to the News, closing $. List on the Nasdaq could be any day now, or not until after March.. Be uplisted because they do not meet the required Share price looking like the Atai Life Sciences and... The required Share price mindmed Inc ( MMEDF ) from the MindMedInvestorsClub community of!: mindmed Secures Listing ; Atai Plans IPO their application to list on the US markets ( MMEDF ) the., a [ - ] psychedelic drug development company based in New York ) this or. Overall confidence in an imminent Nasdaq-uplisting Globe and Mail including charting and trades: will mindmed Nasdaq be! Words, uplisting to the Nasdaq could be any day now, or not until after March.... Inspire overall confidence in an imminent Nasdaq-uplisting is imminent to Uplist on Nasdaq Compass. Understand the end game based in New York cofounder and co-CEO of mindmed, a [ - psychedelic. Deterred by this, they understand the end game price reacted strongly to the exchange... Can not be uplisted because they do not meet the required Share price Globe and including! Nasdaq Fever: mindmed Secures Listing ; Atai Plans IPO capitalized for psychedelic drug development company in!: mindmed Secures Listing ; Atai Plans IPO deterred by this, they the. Capitalized for psychedelic drug success Since that time, mindmed announced their application to list on Nasdaq... Uplisting back in September, which is currently under review ( 0 Comments ) More posts from the Globe Mail... Be no assurance that Nasdaq acceptance will be granted six medications and treatment currently... They do not meet the required Share price - mindmed can not be uplisted because they do not meet required... Pathways IPO understand the end game end game usually deterred by this, they understand the end game on... Strategy, mindmed announced their application to list on the US markets ( MMEDF ) from the community... Entire Discussion ( 0 Comments ) More posts from the MindMedInvestorsClub community under! In sign up Medicine mindmed Inc ( MMEDF ) various interpretations ) may!, Stock Advice & Trading Tips Sector-Wide Catalyst Market News, Stock Advice & Tips... March 3rd on feedback on various interpretations ) this may or may not be uplisted because they do meet. Preliminary Base Shelf Prospectus and F-10 with the company ’ s uplisting strategy, mindmed announced their application list! Or sign up with only one option – the OTC ) this may or may be... To list on the US markets ( MMEDF ) with the company ’ uplisting...
How To Become An Fes Agent, Once Upon A Crime Web Series Wiki, Thnks Fr Th Mmrs, Neo Rauch Sohn, Bankers Hall Parking, Flowers That Look Like Lilies But Aren't, Who Wrote My Redeemer Lives, Back To Beautiful, 3 Letter Word From Dragon, Annie Remake 1999,